Oppenheimer Downgrades Endo Pharmaceuticals Holdings Inc (ENDP) to Perform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Endo Pharma (ENDP) Possibly in Talks to Sell Itself - Reuters
January 30, 2013 2:41 PM ESTEndo Pharmaceuticals Holdings (NASDAQ: ENDP) is ripping higher today as Reuters says the pharma might be in talks to sell itself. The stock is now up over 10 percent on the session.
Interested parties include Warner Chilcott (Nasdaq:... More
UPDATE: Endo Pharma (ENDP) shares paused for volatility
January 30, 2013 2:29 PM EST(Updated - January 30, 2013 2:34 PM EST)
Endo Pharmaceuticals Holdings (NASDAQ: ENDP) shares paused for volatility.
UPDATE - Market chatter has Endo potentially being in talks for a sale, though nothing has been confirmed. Shares were up about 9.5 percent at the pause.... More
